Range Financial Group LLC Eli Lilly & CO Transaction History

Range Financial Group LLC

$191 Million
Q1 2024

A detailed history of Range Financial Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Range Financial Group LLC holds 4,165 shares of LLY stock, worth $3.77 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares

4,165

Previous 4,105 1.46%

Holding current value

$3.77 Million

Previous $2.39 Million 35.45%

% of portfolio

1.69%

Previous 1.46%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$592.2 - $792.28 $35,532 - $47,536	60 Added 1.46%	4,165 $3.24 Million
Q4 2023 Jan 10, 2024	BUY	$525.19 - $619.13 $14,705 - $17,335	28 Added 0.69%	4,105 $2.39 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $701,171 - $966,670	1,613 Added 65.46%	4,077 $2.19 Million
Q2 2023 Jul 18, 2023	SELL	$350.74 - $468.98 $77,162 - $103,175	-220 Reduced 8.2%	2,464 $1.16 Million
Q1 2023 Apr 03, 2023	SELL	$310.63 - $364.82 $66,164 - $77,706	-213 Reduced 7.35%	2,684 $921,000

Q4 2022 Jan 13, 2023	BUY	$321.55 - $374.67 $5,466 - $6,369	17 Added 0.59%	2,897 $0
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $289,068 - $329,423	-975 Reduced 25.29%	2,880 $931,000
Q2 2022 Jul 11, 2022	SELL	$278.73 - $327.27 $224,377 - $263,452	-805 Reduced 17.27%	3,855 $1.25 Million
Q1 2022 May 18, 2022	SELL	$234.69 - $291.66 $11,969 - $14,874	-51 Reduced 1.08%	4,660 $1.33 Million
Q4 2021 Jul 11, 2022	SELL	$224.85 - $279.04 $26,082 - $32,368	-116 Reduced 2.4%	4,711 $1.3 Million
Q3 2021 Jul 11, 2022	SELL	$221.6 - $272.71 $32,575 - $40,088	-147 Reduced 2.96%	4,827 $1.12 Million
Q2 2021 Jul 11, 2022	BUY	$180.55 - $233.54 $141,551 - $183,095	784 Added 18.71%	4,974 $1.14 Million
Q1 2021 Jul 11, 2022	BUY	$164.32 - $212.72 $688,500 - $891,296	4,190 New	4,190 $783,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Range Financial Group LLC with notifications on news.

Account

Range Financial Group LLC Eli Lilly & CO Transaction History